Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Survival Estimates Given to Patients with Stage 4 Breast Cancer Are Rarely Correct

Survival Estimates Given to Patients with Stage 4 Breast Cancer Are Rarely Correct

A new approach is emerging regarding estimated survival communicated to patients with advanced breast cancer. Under this approach, giving a single survival time is wrong, and its accuracy is disputed. Patients should therefore be approached differently and should not be given a single average number.

According to the World Health Organization, with 2.1 million diagnoses annually, breast cancer is the most common cancer among women. Compared with other cancers, breast cancer is easily treatable, but in advanced stages, after metastasis occurs, patient survival rates decline. Patients with advanced breast cancer and their relatives therefore want to learn their average remaining survival from their doctors so they can plan for the future. Speaking in Lisbon, the capital of Portugal, at the 5th International Consensus Conference for Advanced Breast Cancer , Dr. Kiely reported that patients with advanced breast cancer attending her clinic often ask questions such as “Will I be able to attend my daughter’s wedding?” so they can make future plans.

According to Dr. Kiely’s findings, advances in breast cancer treatment in recent years have not yet been reflected in the statistics, contributing to single-number estimates given to patients being correct only 20-30% of the time. She therefore suggests that rather than making a single-number estimate specific to the case, presenting three different scenarios may be much better. These three scenarios consist of:

  • best-case survival,
  • worst-case survival and
  • average survival.

To test this method, researchers worked with 146 patients given survival estimates by 33 cancer specialists. Of the 146 participants in the study, 91% found the three-scenario estimate helpful, and 88% said this approach helped them plan for the future and better understand the possible outcomes. Of the participants, 77% thought this approach was more optimistic and equal than they had expected.

This approach enables patients to prepare for the worst-case scenario while also planning their future around the best-case scenario, and it benefits patients psychologically.

Sources

Thursday 14 November: abstract no IN05, 14:50 hrs GMT, session on Meaningful clinical benefit: how to define, evaluate and communicate, “Estimating and communicating survival times for each ABC patient”, by Belinda Kiely.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Survival Estimates Given to Patients with Stage 4 Breast Cancer Are Rarely Correct

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy